Elisabetta Zulato
Padova, Italy
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 32 publications
Harmonization trial on ESR1 testing strategies in ER+/HER2- breast cancer patients: an Italian experience.
Journal: The journal of liquid biopsy
Published: July 04, 2025
Liver kinase B1 expression is associated with improved prognosis and tumor immune microenvironment features in small cell lung cancer.
Journal: Frontiers in oncology
Published: December 28, 2024
Aspirin-triggered DHA metabolites inhibit angiogenesis.
Journal: Frontiers in pharmacology
Published: November 08, 2024
NGS detection of gene rearrangements and METexon14 mutations in liquid biopsy of advanced NSCLC patients: A study of two Italian centers.
Journal: The journal of liquid biopsy
Published: January 24, 2024
Longitudinal liquid biopsy predicts clinical benefit from immunotherapy in advanced non-small cell lung cancer.
Journal: NPJ precision oncology
Published: January 09, 2024
Non-Small Cell Lung Cancer Testing on Reference Specimens: An Italian Multicenter Experience.
Journal: Oncology and therapy
Published: September 08, 2023
Metabolic classification of non-small cell lung cancer patient-derived xenografts by a digital pathology approach: A pilot study.
Journal: Frontiers in oncology
Published: October 14, 2022
Diagnostic accuracy of circulating free DNA testing for the detection of KRAS mutations in non-small cell lung cancer: A systematic review and meta-analysis.
Journal: Frontiers in genetics
Published: August 09, 2022
EGFR T790M testing through repeated liquid biopsy over time: a real-world multicentric retrospective experience.
Journal: Journal of thoracic disease
Published: June 02, 2022
Longitudinal liquid biopsy anticipates hyperprogression and early death in advanced non-small cell lung cancer patients treated with immune checkpoint inhibitors.
Journal: British journal of cancer
Published: February 24, 2022
Implementation of Next Generation Sequencing-Based Liquid Biopsy for Clinical Molecular Diagnostics in Non-Small Cell Lung Cancer (NSCLC) Patients.
Journal: Diagnostics (Basel, Switzerland)
Published: June 29, 2021
Last Updated: 09/26/2026